Envestnet Asset Management Inc. increased its stake in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 6.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 185,754 shares of the company's stock after purchasing an additional 11,343 shares during the period. Envestnet Asset Management Inc. owned 0.25% of Schrödinger worth $3,583,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently bought and sold shares of the stock. Avanza Fonder AB acquired a new stake in shares of Schrödinger during the fourth quarter worth $577,000. Barclays PLC lifted its position in Schrödinger by 421.6% during the 3rd quarter. Barclays PLC now owns 107,554 shares of the company's stock worth $1,995,000 after acquiring an additional 86,933 shares during the period. Raymond James Financial Inc. purchased a new stake in Schrödinger during the 4th quarter valued at about $325,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Schrödinger by 60.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,510,518 shares of the company's stock valued at $67,718,000 after purchasing an additional 1,319,464 shares during the period. Finally, Amundi raised its stake in shares of Schrödinger by 197.7% in the fourth quarter. Amundi now owns 26,753 shares of the company's stock worth $544,000 after purchasing an additional 17,766 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
SDGR has been the topic of a number of recent research reports. KeyCorp upped their target price on Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Piper Sandler cut their price objective on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Schrödinger presently has an average rating of "Buy" and a consensus target price of $33.00.
View Our Latest Stock Analysis on Schrödinger
Insider Activity at Schrödinger
In other news, insider Karen Akinsanya sold 16,723 shares of the business's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $25.09, for a total transaction of $419,580.07. Following the completion of the sale, the insider now owns 15,625 shares of the company's stock, valued at $392,031.25. The trade was a 51.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Geoffrey Craig Porges sold 5,491 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the completion of the transaction, the chief financial officer now directly owns 27,544 shares in the company, valued at $599,357.44. This represents a 16.62 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 8.60% of the stock is owned by company insiders.
Schrödinger Trading Up 1.2 %
Schrödinger stock traded up $0.32 during mid-day trading on Friday, hitting $26.45. The company had a trading volume of 832,106 shares, compared to its average volume of 836,416. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of -11.30 and a beta of 1.77. The company's fifty day moving average is $22.14 and its 200-day moving average is $21.30. Schrödinger, Inc. has a 12-month low of $16.60 and a 12-month high of $28.47.
Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm had revenue of $88.32 million for the quarter, compared to analysts' expectations of $83.20 million. As a group, sell-side analysts expect that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.
About Schrödinger
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Recommended Stories

Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.